Niagen Bioscience Inc
General ticker "NAGE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $626.1M (TTM average)
Niagen Bioscience Inc does not follow the US Stock Market performance with the rate: -24.9%.
Estimated limits based on current volatility of 2.4%: low 3.18$, high 3.34$
Factors to consider:
- Earnings expected soon, date: 2026-08-04 amc
- Current price 22.0% below estimated low
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [4.36$, 8.42$]
- 2026-12-31 to 2027-12-31 estimated range: [4.26$, 8.21$]
Financial Metrics affecting the NAGE estimates:
- Positive: with PPE of 41.0 at the end of fiscal year the price was low
- Positive: 7.78 < Operating profit margin, % of 11.05
- Positive: Return on assets ratio (scaled to [-100,100]) of 14.04 > 6.08
- Negative: negative Industry operating income (median)
- Negative: Industry earnings per price (median), % of -12.84 <= 0
- Negative: Shareholder equity ratio, % of 71.93 > 63.79
- Negative: Inventory ratio change, % of 5.70 > 0.80
- Negative: negative Industry operating cash flow (median)
- Negative: Operating cash flow per share per price, % of 2.59 <= 6.73
Short-term NAGE quotes
Long-term NAGE plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $83.57MM | $99.60MM | $129.42MM |
| Operating Expenses | $89.17MM | $91.87MM | $115.13MM |
| Operating Income | $-5.60MM | $7.73MM | $14.30MM |
| Non-Operating Income | $0.66MM | $1.13MM | $3.90MM |
| R&D Expense | $4.96MM | $6.02MM | $6.33MM |
| Income(Loss) | $-4.94MM | $8.86MM | $18.19MM |
| Taxes | $0.00MM | $0.30MM | $0.81MM |
| Net Income(Loss)* | $-4.94MM | $8.55MM | $17.38MM |
| Stockholders Equity | $28.46MM | $46.09MM | $76.53MM |
| Inventory | $14.53MM | $9.19MM | $20.42MM |
| Assets | $54.96MM | $68.28MM | $106.41MM |
| Operating Cash Flow | $7.12MM | $12.11MM | $13.44MM |
| Capital expenditure | $0.15MM | $0.16MM | $0.29MM |
| Investing Cash Flow | $-0.14MM | $-0.14MM | $-0.29MM |
| Financing Cash Flow | $-0.09MM | $5.37MM | $6.98MM |
| Earnings Per Share** | $-0.07 | $0.10 | $0.22 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.